Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lily Olson"'
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234065 (2020)
BackgroundThe association between sodium-glucose cotransporter 2 inhibitors (SGLT2i's) and lower extremity amputation is unclear.PurposeTo systematically review randomized control trials (RCTs) and observational studies quantifying risk of lower extr
Externí odkaz:
https://doaj.org/article/cd85e32ccb90450989ebdbd3f3b69224
Autor:
Joshua M. Sharfstein, Peter Lurie, G. Caleb Alexander, Lily Olson, James Heyward, Elizabeth A. Stuart
Publikováno v:
JAMA internal medicine. 180(2)
Importance Extended-release/long-acting (ER/LA) opioids have caused substantial morbidity and mortality in the United States, yet little is known about the efforts of the US Food and Drug Administration (FDA) and drug manufacturers to reduce adverse
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0234065 (2020)
PLoS ONE, Vol 15, Iss 6, p e0234065 (2020)
BackgroundThe association between sodium-glucose cotransporter 2 inhibitors (SGLT2i's) and lower extremity amputation is unclear.PurposeTo systematically review randomized control trials (RCTs) and observational studies quantifying risk of lower extr
Autor:
G. Caleb Alexander, Peter Lurie, Lily Olson, Joshua M. Sharfstein, Jeffrey Eric Rollman, James Heyward
Publikováno v:
JAMA. 321(7)
Importance Transmucosal immediate-release fentanyls (TIRFs), indicated solely for breakthrough cancer pain in opioid-tolerant patients, are subject to a US Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) to prevent t